Novartis, Verastem & Cepheid Making Biotech Headlines On Friday By: Benzinga via Benzinga February 13, 2015 at 15:32 PM EST Novartis AG (ADR) (NYSE: NVS) obtained approval for an accelerated review of an experimental heart-failure treatment Friday, while ... Read More >> Related Stocks: Novartis Ag ADR Pfizer Verastem Inc